White Paper

From Open Cleanrooms To Closed Systems – What Is Driving The Change?

Ecolab - open RABS

Traditionally, aseptic processing has been conducted in open cleanroom environments, relying on air filtration and extensive gowning to minimize contamination. However, the inherent risk of human contamination has led to regulatory bodies advocating for the segregation of personnel from critical processing zones.

This white paper explores the driving forces behind this shift, examining the increasing emphasis on closed systems and barrier technologies like Restricted Access Barrier Systems (RABS) and isolators. It delves into the regulatory perspectives, particularly the impact of documents like GMP Annex 1, which outlines the expectations for minimizing contamination risk in aseptic operations. Understanding these changes is crucial for any organization involved in sterile drug production.

Download this white paper to gain insights into how regulations and technological advancements are shaping the future of aseptic processing.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene